Incanthera ltd
WebPhone Number 441513315220. Incanthera Ltd. develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific matrix … WebJun 21, 2016 · Incanthera Ltd. (Incanthera) is a biopharmaceutical company which discovers and develops pharmaceutical products for the treatment of cancer. Its drug candidates under development include ICT2588, a vascular disrupting agent, based on the tumor-blasting technology; and ICT03-Es5, a targeted bioreductive agent; which are …
Incanthera ltd
Did you know?
WebThe pipeline guide evaluates Bladder Cancer (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. The pipeline guide encapsulates all the dormant and discontinued pipeline projects. WebDeveloped by Prof Robert Falconer, Prof Paul Loadman and jointly funded by Cancer Research UK and Yorkshire Cancer Research the technology formed the basis for the launch of Incanthera Ltd (now plc), an ICT/University of Bradford spin-out company and now licenced to Ellipses Pharma.
WebN4 Pharma top competitors include: Ailse Oncology Ltd, Vaccicure Ltd, Incanthera Ltd, InnoCore How do I contact N4 Pharma? N4 Pharma contact info: Phone number: +44 1332690061 Website: www.n4pharma.com What does N4 Pharma do? WebMore for INCANTHERA PLC (11026926) Registered office address 76 King Street, Manchester, England, M2 4NH . Company status Active Company type Public limited Company Incorporated on 23 October 2024. Accounts. Next accounts made up to 31 March 2024 due by 30 September 2024 ...
WebIncanthera Ltd. develops cancer treatment drugs. Its ICT-2588 is a lead compound that is activated within solid tumours by a specific
WebIncanthera is committed to the development of novel treatments for solid tumours (cancers), and licensing these to large pharmaceutical companies. View what we do SOL … Incanthera is a UK-based, dermatology and oncology therapeutics company focusing … The Company’s strategy of Acquire, Prepare, Commercialise is built on … Financial Calendar. December 07th , 2024 Half-yearly results for the six months … Latest from Incanthera. 2024; 2024; 2024; Archive March 13th, 2024 Director’s … Head Office: Incanthera Ltd 76 King Street Manchester M2 4NH, UK T: 0161 817 … The sustainability of Incanthera is evident in its mission statement: Transformative … The Company has created and continues to develop a rich pipeline of proprietary, … We are not currently recruiting at this time. If you would like to get in touch, please … Financial Calendar. December 07th , 2024 Half-yearly results for the six months …
WebThe Company is a specialist oncology company focused on transforming cancer treatment by creating environments in which cancer cannot survive. It seeks to identify and develop innovative solutions to current clinical, commercially relevant unmet needs, utilising new technology from leading academic institutions.The Company’s current lead product and … first time right self appraisal commentsWebNov 8, 2015 · This report provides comprehensive information on the current therapeutic developmental pipeline of Incanthera Ltd.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. campgrounds in eastham maWebIncanthera debuts...Newco Incanthera Ltd. (Merseyside, U.K.) raised L375,000 ($574,000) in a seed round led by the North West Fund for Biomedical... Read More. BioCentury Jan 9, 2012. Financial News. Ai2 completes venture financing first time right synonymsWebIncanthera is a specialist oncology company focused on innovative technologies in oncology and dermatology. It seeks to identify and develop innovative solutions to current clinical, … campgrounds in east peoria ilWebIncanthera PLC is a UK-based, dermatology and oncology therapeutics company focusing on drug discovery and development of targeted medicines for the treatment of cancer. Deep dive We explore the... campgrounds in eastport maineWebBetween 2014 and 2024 Pawel served as IP and R&D Manager and later as a Chief Operating Officer in UK based oncology focused business Incanthera Ltd. During this time, he has been responsible for portfolio of over 100 patents and 4 new therapeutics drugs in preclinical and early clinical stage of development. campgrounds in eastern upper peninsula miWebJun 12, 2024 · Incanthera Ltd Pre-IPO research – targeting the warheads 12 Jun 2024 / Corporate research By Dr Martin Hall, Dr Dorothea Hill, Dr Gregoire Pave. Download full report. Incanthera is a spin-out from the University of Bradford’s Institute of Cancer Therapeutics to exploit development opportunities being generated from this prestigious ... first time right 中文